Rikkivety (Finnish Wikipedia)

Analysis of information sources in references of the Wikipedia article "Rikkivety" in Finnish language version.

refsWebsite

Global rank Finnish rank

3doi.org

2^nd place

10^th place

3worldcat.org

5^th place

9^th place

3nih.gov

4^th place

12^th place

1tiedetuubi.fi

low place

786^th place

1web.archive.org

1^st place

1inchem.org

4,334^th place

1,611^th place

1ilo.org

1,962^nd place

429^th place

1wiley.com

222^nd place

202^nd place

1bmj.com

1,226^th place

929^th place

bmj.com

ard.bmj.com

J. L. Wallace, D. Vaughan: SAT0520 Marked reduction of osteoarthritis pain with a hydrogen sulfide-releasing naproxen derivative. Annals of the Rheumatic Diseases, 1.6.2017, nro Suppl 2, s. 972–972. doi:10.1136/annrheumdis-2017-eular.1040 ISSN 0003-4967 Artikkelin verkkoversio. (englanniksi)

doi.org

dx.doi.org

Andreas Papapetropoulos, John L. Wallace, Rui Wang: From primordial gas to the medicine cabinet. British Journal of Pharmacology, 2020, nro 4, s. 715–719. PubMed:31726475 doi:10.1111/bph.14929 ISSN 1476-5381 Artikkelin verkkoversio. (englanniksi)^{[vanhentunut linkki]}
John L. Wallace, Peter Nagy, Troy D. Feener, Thibault Allain, Tamás Ditrói, David J. Vaughan: A proof-of-concept, Phase 2 clinical trial of the gastrointestinal safety of a hydrogen sulfide-releasing anti-inflammatory drug. British Journal of Pharmacology, 2020-02, nro 4, s. 769–777. PubMed:30834513 doi:10.1111/bph.14641 ISSN 1476-5381 Artikkelin verkkoversio.
J. L. Wallace, D. Vaughan: SAT0520 Marked reduction of osteoarthritis pain with a hydrogen sulfide-releasing naproxen derivative. Annals of the Rheumatic Diseases, 1.6.2017, nro Suppl 2, s. 972–972. doi:10.1136/annrheumdis-2017-eular.1040 ISSN 0003-4967 Artikkelin verkkoversio. (englanniksi)

ilo.org

Rikkivedyn kansainvälinen kemikaalikortti

inchem.org

http://www.inchem.org/documents/cicads/cicads/cicad53.htm#9.0

nih.gov

pubmed.ncbi.nlm.nih.gov

Andreas Papapetropoulos, John L. Wallace, Rui Wang: From primordial gas to the medicine cabinet. British Journal of Pharmacology, 2020, nro 4, s. 715–719. PubMed:31726475 doi:10.1111/bph.14929 ISSN 1476-5381 Artikkelin verkkoversio. (englanniksi)^{[vanhentunut linkki]}
John L. Wallace, Peter Nagy, Troy D. Feener, Thibault Allain, Tamás Ditrói, David J. Vaughan: A proof-of-concept, Phase 2 clinical trial of the gastrointestinal safety of a hydrogen sulfide-releasing anti-inflammatory drug. British Journal of Pharmacology, 2020-02, nro 4, s. 769–777. PubMed:30834513 doi:10.1111/bph.14641 ISSN 1476-5381 Artikkelin verkkoversio.

ncbi.nlm.nih.gov

John L. Wallace, Peter Nagy, Troy D. Feener, Thibault Allain, Tamás Ditrói, David J. Vaughan: A proof-of-concept, Phase 2 clinical trial of the gastrointestinal safety of a hydrogen sulfide-releasing anti-inflammatory drug. British Journal of Pharmacology, 2020-02, nro 4, s. 769–777. PubMed:30834513 doi:10.1111/bph.14641 ISSN 1476-5381 Artikkelin verkkoversio.

tiedetuubi.fi

Uusi suprajohde - mullistavan lämmin ja hyvin epäkäytännöllinen | Tiedetuubi www.tiedetuubi.fi. Arkistoitu 21.8.2015. Viitattu 19.8.2015.

web.archive.org

Uusi suprajohde - mullistavan lämmin ja hyvin epäkäytännöllinen | Tiedetuubi www.tiedetuubi.fi. Arkistoitu 21.8.2015. Viitattu 19.8.2015.

wiley.com

bpspubs.onlinelibrary.wiley.com

Andreas Papapetropoulos, John L. Wallace, Rui Wang: From primordial gas to the medicine cabinet. British Journal of Pharmacology, 2020, nro 4, s. 715–719. PubMed:31726475 doi:10.1111/bph.14929 ISSN 1476-5381 Artikkelin verkkoversio. (englanniksi)^{[vanhentunut linkki]}

worldcat.org

Andreas Papapetropoulos, John L. Wallace, Rui Wang: From primordial gas to the medicine cabinet. British Journal of Pharmacology, 2020, nro 4, s. 715–719. PubMed:31726475 doi:10.1111/bph.14929 ISSN 1476-5381 Artikkelin verkkoversio. (englanniksi)^{[vanhentunut linkki]}
John L. Wallace, Peter Nagy, Troy D. Feener, Thibault Allain, Tamás Ditrói, David J. Vaughan: A proof-of-concept, Phase 2 clinical trial of the gastrointestinal safety of a hydrogen sulfide-releasing anti-inflammatory drug. British Journal of Pharmacology, 2020-02, nro 4, s. 769–777. PubMed:30834513 doi:10.1111/bph.14641 ISSN 1476-5381 Artikkelin verkkoversio.
J. L. Wallace, D. Vaughan: SAT0520 Marked reduction of osteoarthritis pain with a hydrogen sulfide-releasing naproxen derivative. Annals of the Rheumatic Diseases, 1.6.2017, nro Suppl 2, s. 972–972. doi:10.1136/annrheumdis-2017-eular.1040 ISSN 0003-4967 Artikkelin verkkoversio. (englanniksi)